Article
Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Cancer - 15 Aug 2009
Renneville Aline, Boissel Nicolas, Zurawski Virginie, Llopis Laura, Biggio Valéria, Nibourel Olivier, Philippe Nathalie, Thomas Xavier, Dombret Hervé, Preudhomme Claude
Abstract excerpt
BACKGROUND: Wilms tumor 1 (WT1) is a transcription factor that is overexpressed in most acute myeloid leukemias (AMLs). Recently, 2 groups reported that WT1 mutations occur in approximately 10% of normal karyotype AMLs and are an independent predictor of poor outcome in this subgroup of patients with AML. METHODS: The authors studied a cohort of 268 young adults (ages 15-50 years) with AML who were treated on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
